About 50 Trademarks found that are owned by CelularIty Inc.

Amniotic membrane allograft; biological membrane for use in providing the extracellular matrix and repairing damaged tissue; biological membrane for use in repairing damaged tissue; biological membrane that serves as a natural scaffold; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds, ulcers and repairing damaged tissue

flowable and particulate material, namely, human placental biological connective tissue for the replacement or supplementation of damaged or inadequate integumental tissue

bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen

Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting

Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting

Research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and technological services, namely, scientific research, analysis, and testing in the field of genomics, biotechnology, and pharmaceuticals; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing; research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals

LIE BANK BY CELULARITY

isolation, collection, and banking of umbilical cord tissue perivascular stem cells; cord blood and stem cell bank services; collection, testing, and preservation of blood and blood components for medical treatment and medical diagnostics; collection and testing of tissue and stem cells for medical treatment and medical diagnostics

Flowable and particulate material, namely, human placental biological connective tissue for the replacement or supplementation of damaged or inadequate integumental tissue

storage and retrieval of tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research

Collection, testing, and preservation of blood and blood components for medical treatment and medical diagnostics; collection and testing of tissue and stem cells for medical treatment and medical diagnostics

The mark consists of the word "LIFEBANK" in stylized letters.

umbilical cord tissue perivascular stem cell cryogenic preservation

storage and retrieval of tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research

The color(s) pink and gray is/are claimed as a feature of the mark.